Somatic mutations in GRM1 has been reported in wide varieties of tumors such as melanoma, breast carcinoma, colon carcinoma, lung adenocarcinoma, brain tumors, heamatopoitic, and lymphoid tissue [15]. This evidence concerns the gene GRM1 and colon carcinoma.